Autopsy report · NCT03647085

Data Collection Atrial Fibrillation Exploratory Study

“Due to COVID-19 and resourcing challenges”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 months before it stopped.
• 27 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Boston Scientific Corporation

Sponsor type

Industry

Conditions

Atrial Fibrillation; Atrial Flutter

Interventions

Wearable cardiac monitor

Participants

27

Sites

1

Countries

United States

Trials that died the same way

• Choice of Modality of Follow up for Medication Abortion
  “COVID-19 Impacted Service Delivery and Research Infrastructure” (70% match in meaning)
• A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant
  “Due to COVID-19 disruption” (69% match in meaning)
• High Risk Outpatient Intern-led Care (HeROIC) Clinic Initiative
  “Covid-19, funding” (69% match in meaning)
• RESIST-2: 2nd-line ART for HIV-2 Infection
  “COVID-19 and Funding” (68% match in meaning)
• Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families
  “Due to COVID-19 pandemic” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.